ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Cardiovascular Disease

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

14,329Medicare Part D Prescriptions Filled, Including Refills

Rank: 8 out of 335

$892K Total Retail Price of All Prescriptions

Rank: 5 out of 335

662 Patients Receiving at Least One Drug in Part D
90%Patients 65 Years and Older
23% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Tennessee
Lower avg

Schedule Two
Controlled Substances

4% of this provider’s 662 patients filled at least one prescription for a schedule two drug, compared to an average of 0%.

Schedule Three
Controlled Substances

9% of this provider’s 662 patients filled at least one prescription for a schedule three drug, compared to an average of 1%.

Risky Drugs to Seniors

1% of this provider’s 13,017 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 0%.

Brand Name Drugs

27% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$62 was the average price of a prescription from this provider, compared to $53 among peers.

Prescriptions per Patient

22 is the average number of prescriptions (including refills) per patient, compared to an average of 11.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Tennessee
FUROSEMIDE 840 772 1 6
SIMVASTATIN 775 701 2 4
METOPROLOL SUCCINATE 696 644 3 9
RAMIPRIL 391 375 4 23
HYDROCHLOROTHIAZIDE 377 367 5 19
CRESTOR 367 316 6 17
CARVEDILOL 365 329 7 1
AMLODIPINE BESYLATE 363 328 8 5
POTASSIUM CHLORIDE 356 308 9 18
NIASPAN 352 305 10 35
WARFARIN SODIUM 329 301 11 8
DIGOXIN 323 276 12 14
METOPROLOL TARTRATE 313 286 13 3
CLOPIDOGREL 307 292 14 7
ATORVASTATIN CALCIUM 301 280 15 11
HYDROCODONE-ACETAMINOPHEN 287 195 S3 16 55
PLAVIX 245 237 17 12
LISINOPRIL 191 187 18 2
ZOLPIDEM TARTRATE 184 155 19 69
OMEPRAZOLE 183 173 20 29
TERAZOSIN HCL 182 182 21 73
LOVAZA 179 168 22 78
LEVOTHYROXINE SODIUM 177 177 23 36
KLOR-CON 10 157 127 24 60
LOSARTAN POTASSIUM 156 145 25 16
CLONIDINE HCL 153 134 26 33
KLOR-CON M20 153 147 26 39
MECLIZINE HCL 142 127 28 125
AMIODARONE HCL 141 116 29 21
LOSARTAN-HYDROCHLOROTHIAZIDE 132 118 30 45
PROPAFENONE HCL 131 128 31 50
ATENOLOL 126 119 32 15
HYDRALAZINE HCL 123 105 33 26
SPIRONOLACTONE 101 84 34 20
TRICOR 100 89 35 74
NITROSTAT 96 79 36 22
ISOSORBIDE MONONITRATE ER 93 67 37 10
LIPITOR 93 88 37 40
DOXAZOSIN MESYLATE 87 87 39 57
GABAPENTIN 82 82 40 71
MULTAQ 81 81 41 41
LIVALO 72 71 42 127
ENALAPRIL MALEATE 71 71 43 38
ALLOPURINOL 69 67 44 68
INDAPAMIDE 68 68 45 94
ZETIA 66 52 46 34
SOTALOL 64 64 47 24
GEMFIBROZIL 63 50 48 91
PRADAXA 60 60 49 32
LANOXIN 59 59 50 130
CLONIDINE 59 48 50 115
PRAVASTATIN SODIUM 54 50 52 13
AMOXICILLIN 54 52 52 188
TRIAMTERENE-HCTZ 54 48 52 46
MINOXIDIL 54 43 52 117
VYTORIN 53 44 56 80
QUINAPRIL HCL 52 52 57 76
METFORMIN HCL 51 47 58 67
RANEXA 51 50 58 25
FENOFIBRATE 50 50 60 47
DIOVAN 50 48 60 28
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 8, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.